- Home
- NXTS vs XXII Comparison
NXTS vs XXII Comparison
Compare NXTS & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXTS | XXII |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | Israel | United States |
| Employees | 9 | N/A |
| Industry | Agricultural Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.3M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | NXTS | XXII |
|---|---|---|
| Price | $5.84 | $0.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 39.0K | ★ 1.3M |
| Earning Date | 05-16-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 69.96 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,832,530.00 |
| Revenue This Year | N/A | $370.28 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.55 | $0.51 |
| 52 Week High | $6.25 | $11.37 |
Technical Indicators
Market Signals| Indicator | NXTS | XXII |
|---|---|---|
| Relative Strength Index (RSI) | 65.71 | 22.08 |
| Support Level | $3.97 | $0.51 |
| Resistance Level | $6.23 | $1.15 |
| Average True Range (ATR) | 0.71 | 0.08 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 65.20 | 12.14 |
Price Performance
Historical ComparisonAbout NXTS Nexentis Technologies Inc. Common Stock
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.